Manufacturer record

Elfin Drugs Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by Elfin Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between November 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to Elfin Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2019 to Nov 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2019
5
Products affected
Description
Most common failure
Nov 2025
Latest alert

Flagged batches per year

2019 · 12023 · 12024 · 12025 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Telmisartan Tablets IP 40 mg ED24290Mfg 2024-09 · Exp 2026-08 The sample is declared to be Not of Standard Quality for the reason stated under Description.Description CDL, KolkataCDSCO lab Nov 2025
Telmisartan Tablets IP 40 mg ED25088Mfg 2025-07 · Exp 2027-06 The sample is declared to be Not of Standard Quality for the reason stated under Description.Description CDL, KolkataCDSCO lab Nov 2025
Metformin Hydrochloride Tablets IP(Elmet-500) G-358/5431Mfg 2023-12 · Exp 2025-11 The sample does not conform to IP with respect to test for DescriptionDescription SDTL, JharkhandState lab Jul 2025
ELTHROM-200 (Azithromycin oral suspension IP) 15ML G-042/5045Mfg 2023-05 · Exp 2025-04 CONTENT OF AZITHROMYCIN IN THE SAMPLE IS LESS (72.96% OF LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT-90.0%- 110.0%)Labelling State Lab MaharashtraState lab Jun 2024
Romavit Capsules (Amino Acids, Biotin, Folic Acid, Vitamins and Minerals Capsules) K22CS-36Mfg 2022-05 · Exp 2023-10 Description, Assay of N-Acetyl CysteineAssay CDL KolkataCDSCO lab Jan 2023
Albendazole Tablets I.P. (C-Bend) G002/2561Mfg 2019-04 · Exp 2021-03 DissolutionDissolution RDTL GuwahatiState lab Nov 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.